Immix Biopharma, Inc.

NASDAQ:IMMX

2.09 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -21.698-15.596-8.23-24.384-1.148-0.973
Depreciation & Amortization 0.1150.0050.0020.0020.0020.001
Deferred Income Tax 00022.84600
Stock Based Compensation 3.0212.5660.6240.21900
Change In Working Capital 01.6530.195-0.3910.1660.182
Accounts Receivables 00-0.2360.0980.058-0.036
Inventory 000.236-0.098-0.0580.036
Accounts Payables 4.4022.4341.132-0.106-0.0040.123
Other Working Capital 0-0.782-0.937-0.2850.170.059
Other Non Cash Items 3.96700.10.1180.575-0.084
Operating Cash Flow -14.595-11.371-7.408-1.589-0.405-0.79
Investing Activities:
Investments In Property Plant And Equipment -1.178-0.0520-0.0010-0.007
Acquisitions Net 000000
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites 000-0.00100
Investing Cash Flow -1.178-0.0520-0.0010-0.007
Financing Activities:
Debt Repayment 0000.201.05
Common Stock Issued 15.94615.696018.64900
Common Stock Repurchased 00-0.1000
Dividends Paid 000000
Other Financing Activities 0.002-0.229-0.057000
Financing Cash Flow 15.94915.4643.23218.84901.05
Other Information:
Effect Of Forex Changes On Cash -0.0040.033-0.032-0.0050.0620.019
Net Change In Cash 0.1724.073-4.20817.253-0.3430.272
Cash At End Of Period 17.68217.5113.43717.6440.3910.734